Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases

BMC Pharmacology

Volumn 2, Issue , 2002, Pages

  Kramer, H Kenneth ^a,b   Onosprishvili, Irma ^b   Andria, Matthew L ^b   Hanna, Kayane ^b   Sheinkman, Karina ^b   Haddad, Lisa B ^b   Simon, Eric J ^b  

^a FORDHAM UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; ISOENZYME; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLIOMA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 2642533719     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-2-5     Document Type: Article

References (29)

1. Gutkind JS: The pathway connecting G-protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 1998, 273:1839-1842
2. Fukuda K, Kato S, Morikawa H, Shoda T, Mori K: Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 1996, 67:1309-16
3. Lou LG, Zhang Z, Ma L, Pei G: Nociceptin/orphanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor. J. Neurochem. 1998, 70:1316-22
4. Li JG, Luo LY, Krupnick JG, Benovic JL, Liu-Chen LY: U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J. Biol. Chem. 1999, 274:12087-94
5. Burt AR, Sautel M, Wilson MA, Rees S, Wise A, Milligan G: Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. Biochem. J. 1996, 320:227-35
6. Cobb MH: MAP kinase pathways. Prog. Biophys. Mol. Biol. 1999, 71:479-500
7. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A: Signal characteristics of G protein-transactivated EGF receptor. Embo J. 1997, 16:7032-44
8. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ: Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes [see comments]. Science 1999, 283:655-61
9. Kramer HK, Simon EJ: μ- and δ-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology 2000, 39:1707-1719
10. Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ: G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat la fibroblasts. Shc phosphor ylation and receptor endocytosis correlate with activation of ERK kinases. J. Biol. Chem. 1997, 272:31648-56
11. Kramer HK, Andria ML, Simon EJ: Tyrosine phosphorylation of the delta-opioid receptor: evidence for a role in mitogen-activated protein kinase activation and receptor internalization. Biochem. Pharmacol. 2000, 60:781-792
12. Pak Y, O'Dowd BF, Wang JB, George SR: Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase. J. Biol. Chem. 1999, 274:27610-27616
13. Kramer HK, Andria ML, Kushner SA, Esposito DH, Hiller JM, Simon EJ: Mutation of tyrosine 318 (Y318F) in the delta-opioid receptor attenuates agonist-dependent receptor internalization and mitogen-activated protein kinase activation. Mol. Brain Res. 2000, 79:55-66
14. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ: Gbeta/gamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 1997, 272:4637-44
15. Polakiewicz RD, Schieferi SM, Dorner LF, Kansra V, Comb MJ: A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J. Biol. Chem. 1998, 273:12402-6
16. Moon HL, Cavalli A, Bahia DS, Hoffmann M, Massotte D, Milligan G: The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha. J. Neurochem. 2001, 76:1805-13
17. Tso PH, Wong YH: Opioid-induced adenylyl cyclase supersensitization in human embryonic kidney 293 cells requires pertussis toxin-sensitive G proteins other than G(i1) and G(i3). Neurosci. Lett. 2001, 299:25-8
18. Della Rocca GJ, Maudsley S, Daaka Y, Lefkowitz RJ, Luttrell LM: Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J. Biol. Chem. 1999, 274:13978-84
19. Della Rocca GJ, Mukhin YV, Garnovskaya MN, Daaka Y, Clark GJ, Luttrell LM, Lefkowitz RJ, Raymond JR: Serotonin 5-HT1A receptormediated ERK activation requires calcium/calmodulin-dependent receptor endocytosis. J. Biol. Chem. 1999, 274:4749-53
20. Castagliuolo I, Valenick L, Liu J, Pothoulakis C: Epidermal growth factor receptor transactivation mediates Substance P-induced mitogenic responses in U-373 cells. J. Biol. Chem. 2000, 275:26545-26550
21. Law PY, Hom DS, Loh HH: Opiate receptor down-regulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two cellular adaptation processes. Mol. Pharmacol. 1983, 24:413-424
22. Marshall CJ: Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-85
23. Schlessinger J: How receptor tyrosine kinases activate Ras. Trends Biochem. Sci. 1993, 18:273-5
24. Pierce KL, Maudsley S, Daaka Y, Luttrell LM, Lefkowitz RJ: Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and non-sequestering G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 2000, 97:1489-94
25. Schmitt JM, Stork PJS: β2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase B-Raf. J. Biol. Chem. 2000, 275:25342-25350
26. Gutkind JS: Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 1998, 17:1331-1342
27. Buist A, Tertoolen LGJ, den Hertog J: Potentiation of G protein-coupled receptor-induced MAP kinase activation by exogenous EGF receptors in SK-N-MC neuroepithelioma cells. Biochem. Biophys. Res. Comm. 1998, 251:6-10
28. Slowiejko DM, Fisher SK: Radioligand binding measurement of receptor sequestration in intact and permeabilized cells. In: Receptor Signal Transduction Protocols. 1997, 83:243-251
29. Munson PJ, Rodbard D: LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 1980, 107:220-239